Table 3.
Functions | miRNA | Up/down | Targets | Reference | |
---|---|---|---|---|---|
Cardiomyocyte hypertrophy | Pro-hypertrophy | 208 | Up | Trβ1/MYH7 | PMID:19726871 |
27 | Up | Trβ1/MYH7 | PMID:21149577 | ||
27 | Up | PDLIM5 | PMID:32370947 | ||
212/132 | Up | Ang II | PMID:23011132 | ||
22 | Up | SIRT | PMID:23524588 | ||
22 | Up | PTEN | PMID:21618527 | ||
206 | Up | FoXP1 | PMID:26333362 | ||
340 | Up | DMD1 | PMID:26084457 | ||
365 | Up | SKP2 | PMID:28130111 | ||
195 | Up | MFN2 | PMID:31341888 | ||
20 | Up | MFN2 | PMID:31295012 | ||
10 | Down | TNX5 | PMID:28100873 | ||
200 | Down | MLCK | PMID:30680929 | ||
34 | Down | Ang II | PMID:24728149 | ||
1 | Down | CDK6/NFAT | PMID:26699910 | ||
133a | Down | RhoA | PMID:17468766 | ||
Anti-hypertrophy | 1 | Up | FbIn2 | PMID:23612897 | |
541 | Up | MITF | PMID:24722296 | ||
let-7 | Up | CaM | PMID:28123343 | ||
142 | Up | SH2B1 | PMID:30372837 | ||
672 | Up | JUN | PMID:29339068 | ||
144 | Up | MOTR | PMID:30084039 | ||
181 | Down | – | PMID:32538237 | ||
410/495 | Down | – | PMID:26999812 | ||
495 | Down | PTEN | PMID:29566365 |
miRNAs are divided into pro-hypertrophy and anti-hypertrophy according to functions. The pro-hypertrophy of main targets include Trβ1/MYH7, MFN2, and Ang II and the anti-hypertrophy of main targets include MOTR, PTEN, and CaM.